Allergy Therapeutics Names Martin Hopcroft Interim CFO - Quick Facts

Allergy Therapeutics plc (AGY.L) said Monday that it appointed Martin Hopcroft as Interim Chief Financial Officer. Martin will report into Chief Executive Officer, Manuel Llobet. The appointment follows the announcement on 26 May 2022 that Nick Wykeman, CFO, will leave Allergy Therapeutics on 30 November 2022 to pursue non-executive roles.

The company noted that it is continuing its search for a permanent Chief Financial Officer and will make a further announcement in due course.

Martin served as Chief Financial Officer of Novasep SA. He previously served as CFO of formerly listed Cambian Group plc.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
American Honda Motor Co, Inc. has recalled about 2,900 units of 2022 model year Honda TRX90X All-Terrain Vehicles (ATVs) sold in the United States for possible crash and injury hazard, according to a statement issued by the U.S. Consumer Product Safety Commission or CPSC. The Laundress, a unit of Conopco Inc. d/b/a Unilever, is recalling around 8 million laundry and household cleaning products citing risk of exposure to bacteria, U.S. Consumer Product Safety Commission. The recall involves Laundress laundry detergent, fabric conditioner and other cleaning products. Tesla Inc. has delivered its first Semi, a heavy-duty electric truck, to its customer PepsiCo Inc. during an event at its Nevada Gigafactory. The delivery of 500-mile fully electric Semi truck comes five years after the launch of the truck's prototype in 2017. During Thursday night's Semi Delivery Event at Tesla's Sparks, Nevada factory, CEO Elon Musk, with Dan Priestly, ...
Follow RTT